Neither medication requires a bundle commitment
The programme runs across four phases using the COM-B behaviour change model, covering nutrition, physical activity, sleep, and the psychological aspects of eating behaviour
An epidemiologic study by Apnimed, a clinical-stage pharmaceutical company developing AD109, an oral drug candidate for OSA, demonstrated that most people with OSA60.6%are not obese
442 Preclinical studies have documented the inhibitory effects of GLP-1RAs on the development of AS in animal models
The B-Vitamins (B1, B5, B12)- They all assist in producing cellular energy, and metabolizing carbohydrates, proteins, and fats from your food
doi: 10.20945/2359-4292-2023-0123, 12